Singapore, Philippines spearhead medtech across SEA

The Lion City’s Diagnostics Development hub has delivered 400 technologies and four products since 2014.

Singapore and the Philippines are co-leading an ASEAN initiative that aims to commercialise medical diagnostic technologies across the region, according to a press release.

The Diagnostics Development (DxD) Initiative, endorsed in 2018, leverages the Lion City’s Diagnostics Development Hub as well as the Philippines’ ASEAN Network for Drugs, Diagnostics, Vaccines and Traditional Medicines Innovation platform.

Since its launch in 2014, Singapore’s DxD hub has evaluated over 400 technologies and delivered nine products to local companies including cancer diagnostic tests and immunotherapy drugs.

A Strategic Planning Panel composed of experts and stakeholders from ASEAN member states are reviewing projects aimed at addressing diseases such as dengue and tuberculosis.

Ministers from the member states visited the Singapore hub last Friday to learn how it coordinates with the scientific and clinical communities to address unmet medical needs.

Also Read

Dental radiology equipment market to grow by $2.45b by 2028

What to expect with Australia’s $739m Frankston Hospital Redevelopment?

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit